Product Information
CARBIDOPA-LEVODOPA 25-100 TAB is a generic product labeled by Mylan Pharmaceuticals Inc., priced at $0.0724 per EA under NDC 00378008501. Its NADAC has been published 649 times since Nov 28, 2013.
Strength
25; 100 mg/1; mg/1
Manufacturer
Mylan Pharmaceuticals Inc.NDC
00378008501
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
4/22/2026
Active Ingredients
CARBIDOPA; LEVODOPAApproval Type
Generic (ANDA)
FDA Application
ANDA090324On Market Since
5/16/2011
Pharmacological Classes
Price Statistics
The NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has been published 649 times since Nov 28, 2013, and over the history we have for it it has declined 42.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0724 per EA |
|---|---|
| All-time high | $0.1394 (Jun 15, 2022) |
| All-time low | $0.0617 (Nov 20, 2024) |
| 52-week high | $0.0925 |
| 52-week low | $0.0724 |
| Median price | $0.0972 |
| Average price | $0.1007 |
| Largest weekly change | -30.7% (Nov 20, 2024) |
| Weeks tracked | 649 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 6 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 6 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CARBIDOPA-LEVODOPA 25-100 TAB?
The current National Average Drug Acquisition Cost (NADAC) for CARBIDOPA-LEVODOPA 25-100 TAB, manufactured by Mylan Pharmaceuticals Inc., is $0.0724 per EA (NDC 00378008501), effective Apr 29, 2026.
How has the price of CARBIDOPA-LEVODOPA 25-100 TAB changed over time?
Over the history we have for it, the NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has declined 42.3%. It has been tracked across 649 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CARBIDOPA-LEVODOPA 25-100 TAB?
Since Nov 28, 2013, the NADAC for CARBIDOPA-LEVODOPA 25-100 TAB has ranged from a low of $0.0617 (Nov 20, 2024) to a high of $0.1394 (Jun 15, 2022), with a median of $0.0972 per EA.
Are there cheaper alternatives to CARBIDOPA-LEVODOPA 25-100 TAB?
6 NADAC-published products share the same active ingredient, strength, and dosage form as CARBIDOPA-LEVODOPA 25-100 TAB, but none are currently priced below it.
Who manufactures CARBIDOPA-LEVODOPA 25-100 TAB?
CARBIDOPA-LEVODOPA 25-100 TAB (NDC 00378008501) is labeled by Mylan Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification